 | Up a level |
Yang, H; Bouma, B J; Dimopoulos, K; Khairy, P; Ladouceur, M; Niwa, K; Greutmann, M; Schwerzmann, Markus; Egbe, A; Scognamiglio, G; Budts, W; Veldtman, G; Opotowsky, A R; Broberg, C S; Gumbiene, L; Meijboom, F J; Rutz, T; Post, M C; Moe, T; Lipczyńska, M; ... (2020). Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study. International journal of cardiology, 299, pp. 123-130. Elsevier 10.1016/j.ijcard.2019.06.014
Attenhofer, C; Rohrbach, M; Matyas, G; Schönhoff, Florian; Baumgartner, M; Oxenius, D; Carrel, Thierry; Huebler, M; Min, K; De Pasquale, G; Landau, K; Kretschmar, O; Odavic, D; Vogt, P; Faletra, F; Greutmann, M (2015). Marfan-Syndrom: Wissenswertes zu Diagnose und Therapie für die Praxis. Swiss Medical Forum, 15(29-30), pp. 674-683. EMH Swiss Medical Publishers
Tobler, D; Schwerzmann, M; Greutmann, M (2011). Erwachsene mit angeborenem Herzfehler – die Rolle der Grundversorger. PrimaryCare, 11, pp. 232-33. Muttenz: EMH Editores Medicorum Helveticorum - Schweizerischer Ärzteverlag AG
